Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a novel class of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN) ...

By Angela Reinhardt Staff Writer “You have got to be joking,” I thought, laughing a little under my breath. The Progress booth was at the table beside Wayside Animal Clinic. If they brought that big, ...

2025 NFL Draft: Home runs and head-scratchers for Rounds 2-3, including Dillon Gabriel and Shavon Revel Jr.

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase Ib/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 ...

A breakthrough in preclinical data puts CK Life Sciences at the forefront of next-gen immuno-oncology. Abstract 853: ...

OSE Immunotherapeutics Highlights Abstracts Selected for Presentation at ASCO 2025 Featuring proprietary asset Tedopi® and ...

It has been a period of time (just 2.5 weeks, if you can believe it!) since President Donald Trump displayed his posterboard tariff plan in the Rose Garden on April 2. Financial markets have been ...

April 25, 2025 • Researchers using data from the James Webb Space Telescope recently announced they had detected biosignature gases on planet K2-18b. A new analysis of the same data casts doubt ...

Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics that harness the ELANE pathway, today announced the presentation of new preclinical data for its lead drug ...

Additionally, in the framework of a licensing agreement and a collaborative endeavor to support innovative research, Debiopharm and Oncodesign Services will present promising new data illustrating how ...

HONG KONG SAR – Media OutReach Newswire – 22 April 2025 – CK Life Sciences Int’l., (Holdings) Inc. (“the Company”) announced ...